SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-031656
Filing Date
2023-09-05
Accepted
2023-09-05 16:15:45
Documents
24
Period of Report
2023-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 65282
2 ex4-1.htm EX-4.1 183659
3 ex4-2.htm EX-4.2 186918
4 ex4-3.htm EX-4.3 153890
5 ex4-4.htm EX-4.4 152927
6 ex4-5.htm EX-4.5 153907
7 ex4-6.htm EX-4.6 152922
8 ex4-7.htm EX-4.7 165990
9 ex4-8.htm EX-4.8 165916
10 ex4-9.htm EX-4.9 166513
11 ex10-1.htm EX-10.1 436926
12 ex10-2.htm EX-10.2 188195
13 ex10-3.htm EX-10.3 37316
  Complete submission text file 0001493152-23-031656.txt   2808495

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE mrzm-20230830.xsd EX-101.SCH 3015
15 XBRL LABEL FILE mrzm-20230830_lab.xml EX-101.LAB 34240
16 XBRL PRESENTATION FILE mrzm-20230830_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3025
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 231235941
SIC: 2834 Pharmaceutical Preparations